SCHEMBL8337397

SCHEMBL8337397

NC(=O)c1cc(Br)ccc1OCCCCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 3/20 0.54
PDE4B Q07343 3/20 0.54
PDE4C Q08493 3/20 0.54
PDE4D Q08499 3/20 0.54
SIRT2 Q8IXJ6 3/20 0.47
PTGDR2 Q9Y5Y4 2/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
LMNA P02545 2/20 0.47
NR1I2 O75469 1/20 0.47
CHRM2 P08172 1/20 0.47
CYP3A4 P08684 1/20 0.47
ADRA2A P08913 1/20 0.47
MAPT P10636 1/20 0.47
OPRK1 P41145 1/20 0.47
HTR2B P41595 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
KDM4E B2RXH2 2/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8337635 0.99 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DSIRT2
SCHEMBL8337867 0.99 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DSIRT2
SCHEMBL5927145 0.87 PTGDR2 (0.47) PDE4APDE4BPDE4CPDE4DPTGDR2
SCHEMBL4723723 0.83 LRRK2 (0.58) LMNAKDM4EPOLBPARP1
SCHEMBL4970659 0.83 LMNA (0.66) PDE4APDE4BPDE4CPDE4DSIRT2
SCHEMBL8337873 0.83 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DSIRT2
SCHEMBL3993071 0.83 PTGDR2 (0.48) PTGDR2MEN1KMT2ALMNAHTR2B
SCHEMBL16997486 0.79 PTGDR2 (0.48) PTGDR2MEN1KMT2ALMNANR1I2
SCHEMBL8337852 0.78 PTGES (0.59) SIRT2PARP1
SCHEMBL7119572 0.78 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014844-A2 ARYL AND HETEROARYL COMPOUNDS AND METHODS TO MODULATE COAGULATION TRANSTECH PHARMA, INC. (US) 2004-02-19 WO disclosed